Jamal, F.; Elshaer, A.; Odeh, N.B.; Alatout, M.H.; Shahin, T.; Worden, A.R.; Albunni, H.N.; Lizaola-Mayo, B.C.; Jayasekera, C.R.; Chascsa, D.M.H.;
et al. Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Life 2025, 15, 1306.
https://doi.org/10.3390/life15081306
AMA Style
Jamal F, Elshaer A, Odeh NB, Alatout MH, Shahin T, Worden AR, Albunni HN, Lizaola-Mayo BC, Jayasekera CR, Chascsa DMH,
et al. Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Life. 2025; 15(8):1306.
https://doi.org/10.3390/life15081306
Chicago/Turabian Style
Jamal, Fares, Amani Elshaer, Nour B. Odeh, Mayar H. Alatout, Tala Shahin, Astin R. Worden, Hashem N. Albunni, Blanca C. Lizaola-Mayo, Channa R. Jayasekera, David M. H. Chascsa,
and et al. 2025. "Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis" Life 15, no. 8: 1306.
https://doi.org/10.3390/life15081306
APA Style
Jamal, F., Elshaer, A., Odeh, N. B., Alatout, M. H., Shahin, T., Worden, A. R., Albunni, H. N., Lizaola-Mayo, B. C., Jayasekera, C. R., Chascsa, D. M. H., Vargas, H. E., & Aqel, B. A.
(2025). Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Life, 15(8), 1306.
https://doi.org/10.3390/life15081306
